As per the research report, the size of the Asia-Pacific Hematology Market is valued at $ xxx Billion in 2019 and estimated to reach $ xxx Million by the end of 2024 with a growing potential of xxx % during the forecast period 2019-2024.
Hematology is the study of blood and its diseases and blood-forming organs. The medical aspect of hematology is concerned with the treatment and prevention of blood disorders and malignancies, including types of leukemia, hemophilia, sickle-cell anemia and lymphoma. Hematology is also a branch of internal medicine which deals with the physiology, pathology, diagnosis, etiology, prognosis, treatment, and prevention of blood-related disorders.
Key factors such as increasing prevalence of blood related disorders, rising use of automated hematology instruments by diagnostics laboratories, Rising R&D expenditure, advancement in technologies, increasing use of flow cytometry in hematology testing are propelling the growth of the market. slow adoption of the advanced hematology analyzers/instruments in the emerging countries, recall of hematology products, and high cost are hindering the growth of the market.
This research report segmented and sub-segmented into the following categories:
The Top companies leading in the APAC Hematology Market profiled in the report are Siemens AG Healthcare, Johnson & Johnson, Beckman Coulter, Inc., Abbott Laboratories, Thermo Fisher Scientific, Roche, HORIBA Ltd., Sysmex Corporation, Bio-Rad Laboratories Inc., Boule Diagnostics AB, Mindray Medical International Limited.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Products
5.1.1 Introduction
5.1.2 Hematology Analyzers
5.1.2.1 Automated Analyzers
5.1.2.2 Semi-Automated Analyzers
5.1.3 Hematology reagents
5.1.3.1 Products
5.1.3.2 Consumables
5.1.4 Flow cytomers
5.1.5 Hematology cell counters
5.1.6 Slide stainers
5.1.7 Coagulation Analyzers
5.1.8 Hematology testing
5.1.9 Centrifuges
5.1.10 Hemoglobinometers
5.1.11 Others
5.1.12 Y-o-Y Growth Analysis, By Products
5.1.13 Market Attractiveness Analysis, By Products
5.1.17 Market Share Analysis, By Products
5.2 Application
5.2.1 Introduction
5.2.2 Infectious diseases
5.2.3 Cancer
5.2.4 Cardiovascular diseases
5.2.5 Blood Screening
5.2.6 Diabetes
5.2.7 HIV
5.2.8 Autoimmune disorders
5.2.9 Others
5.2.10 Y-o-Y Growth Analysis, By Application
5.2.11 Market Attractiveness Analysis, By Application
5.2.12 Market Share Analysis, By Application
5.3 End users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Clinics
5.3.4 Diagnostic Laboratories
5.3.5 Research and development centers
5.3.6 Others
5.3.7 Y-o-Y Growth Analysis, By End users
5.3.8 Market Attractiveness Analysis, By End usersd
5.3.9 Market Share Analysis, By End users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Products
6.1.3.3 By Application
6.1.3.4 By End users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Products
6.1.4.3 By Application
6.1.4.4 By End users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Products
6.1.5.3 By Application
6.1.5.4 By End users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Siemens AG Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Johnson & Johnson
8.3 Beckman Coulter, Inc.
8.4 Abbott Laboratories
8.5 Thermo Fisher Scientific
8.6 Roche
8.7 HORIBA Ltd.
8.8 Sysmex Corporation
8.9 Bio-Rad Laboratories Inc.
8.10 Boule Diagnostics AB
8.11 Mindray Medical International Limited
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
